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  bjective: Antimicrobial agents in combination with anti-inflammatory drugs have been usually prescribed in both Medicine and
Dentistry. However, few scientific reports support this clinical practice. The aim of this study was to evaluate the effect of betamethasone
and diclofenac sodium on serum and tissue concentration of amoxicillin in rats. Methods: Four polyurethane sponges were implanted in the
back skin of 48 rats. After seven days the animals were divided into 6 groups (n=8). Group 1: amoxicillin (25 mg/kg); G2: diclofenac sodium
(2.5 mg/kg); G3: betamethasone (0.1 mg/kg); G4: diclofenac sodium and amoxicillin; G5: betamethasone and amoxicillin; and G6: 0.9%
sodium chloride solution (1.0 mL - control group). All drugs were administered in a single dose. After 90 minutes, the granulomatous tissues
of each animal were surgically removed and weighed. Blood was collected from cervical plexus, centrifuged and 10µL of serum was placed
on paper discs. In order to estimate amoxicillin concentration, serum and granulomatous tissues were separately submitted to microbiological
assay, which used 108cfu/mL of Staphylococcus aureus ATCC 25923 (penicillin-susceptible strain). After incubation (18 hours, 37oC) the
inhibition zones were measured and compared to a regression curve. Results: No inhibition zones were observed for groups 2, 3 and 6. Tissue
and serum concentrations of both G1 (4.14µg/g and 2.06µg/mL, respectively) and G5 (3.87µg/g and 1.70µg/mL, respectively) showed
statistically significant differences (Kruskal-Wallis, p<0.05) in comparison to G4 (1.45µg/g and 0.41µg/mL, respectively). G1 and G5 did
not differ significantly (p>0.05). Conclusion: Considering single doses, betamethasone did not interfere with amoxicillin levels but diclofenac
sodium reduced both tissue and serum levels of amoxicillin in rats.
Uniterms: Amoxicillin; Betamethasone; Drug interaction.
   bjetivo: A prescrição de antimicrobianos associados a antiinflamatórios é uma prática comum em odontologia, embora na maioria das
vezes não haja justificativa para tal conduta. O objetivo deste trabalho foi avaliar, em um estudo in vivo em ratos, os efeitos da betametasona
e do diclofenaco sódico nas concentrações sérica e tecidual da amoxicilina. Métodos: Foram utilizados 48 ratos Wistar machos (6 grupos,
n=8), com idade de 60 dias. Esponjas de PVC (policlorovinil) foram implantadas em quatro pontos no dorso de cada animal. Após sete dias,
foram administrados por via intragástrica ou intramuscular: Grupo 1: amoxicilina (25 mg/kg); G2: diclofenaco sódico (2,5 mg/kg/i.m.); G3:
betametasona (0,1 mg/kg/i.m.); G4: diclofenaco sódico e amoxicilina; G5: betametasona e amoxicilina; e G6: solução de cloreto de sódio a
0,9% (1,0 mL – grupo controle). Após 90 minutos, foram colhidos 2 tecidos granulomatosos e amostras séricas de cada animal e colocados
em meios de cultura inoculados com 108 ufc/mL de Staphylococcus aureus ATCC 25923. Os halos de inibição foram medidos após 18 horas
de incubação (37ºC), e através do teste microbiológico foram obtidas as concentrações séricas e teciduais da amoxicilina.  Resultados: Não
foram observados halos de inibição para os grupos 2, 3 e 6. As concentrações séricas e teciduais de G1 (4,14µg/g e 2,06µg/mL, respectivamente)
e G5 (3,87µg/g e 1,70µg/mL, respectivamente) demonstraram diferenças estatisticamente significantes (Kruskal-Wallis, p<0,05) em comparação
a G4 (1,45µg/g e 0,41µg/mL, respectivamente). G1 e G5 não apresentaram diferença estatística (p>0,05). Conclusão: Considerando uma
dose única, a betametasona não interferiu nas concentrações sérica e tecidual de amoxicilina, enquanto o diclofenaco sódico reduziu as
concentrações sérica e tecidual de amoxicilina em ratos.
Unitermos: Amoxicilina; Betametasona; Interação medicamentosa.
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INTRODUCTION
Amoxicillin is a widely prescribed aminopenicillin,
primarily for oral use22. It has been used as the first choice in
several odontogenic infections and bacterial endocarditis
prophylaxis. The standard bacterial endocarditis prophylaxis
regimen includes a 2-g single dose of amoxicillin, one hour
before the procedure7.
The oral daily recommended dosage for adult patients is
usually 250 to 500mg TID9 or 875 to 1000mg BID4. For
pediatric patients, depending on the infection severity and
the etiological agent, the dosage is usually 25 to 50mg/kg
TID1,8.
Amoxicillin has been also frequently used in Dentistry
as a substitute for phenoxymethylpenicillin and ampicillin
due to a better oral absorption and larger period of time
between doses. Food does not interfere with either
absorption or plasma concentration of amoxicillin6.
Ninety percent of the administered dose of amoxicillin is
absorbed without molecular modifications13 providing serum
concentration ranging from 7.6 µg/mL to 10.8 µg/mL after
500 mg/po dose in human beings10. In rats, serum
concentration ranged from 28µg/mL and 13µg/mL when 40
mg/kg/po and 7.0 mg/kg/po of amoxicillin were administered,
respectively3,11.
Approximately 60% of oral doses of amoxicillin are
excreted in the urine in unchanged form within six hours by
glomerular filtration (to a limited extent) and tubular
secretion16. PEPT1 (in intestine) and PEPT2 (in kidney) are
H+-coupled peptide transporters that mediate and limit the
transport of amoxicillin27. Other drugs that have affinity for
these transporters could interfere with amoxicillin
bioavailability.
Antimicrobial agents help the host immune system to
kill bacteria. The phagocytic cells are a major component of
host resistance against bacteria and any drug that impairs
their function is likely to increase susceptibility to infection21.
However, the modulation of the inflammatory response of
infectious diseases could be beneficial since the sequelae
relate, in part, to this reaction23.
The association of antimicrobial and anti-inflammatory
agents is relatively common in Dentistry and in Medicine.
This association has been used routinely for prevention of
infection along with the use of corticosteroids, for example.
However, there are few studies regarding the effects of this
association2.
Dexamethasone has been used together with different
antibiotics in the treatment of experimental staphylococcal
endophthalmitis31, and septic nephritis29. Siaperas, et al.25
(2001) observed that dexamethasone (0.5 mg/kg, BID) used
together with vancomycin (30mg/kg every 12 h, IV) reduced
the tissue damage of the aortic valves in experimental
staphylococcal endocarditis and did not affect the
antimicrobial agent effectiveness.
In a rat model, the combination therapy with antibiotics
and steroids was also more effective to reduce, or even to
prevent, the persistence of ear mucosal changes in acute
otitis media than the administration of antibiotics alone19.
However, one of the main side effects of anti-inflammatory
drugs, particularly corticosteroids, is the impairment of
cellular defenses against infection. The reactivation of latent
infections by corticosteroids has proven to be a clinical
problem21.
Non-steroidal anti-inflammatory drugs do not prevent
the synthesis of leukotriene B4 (a potent endogenous
chemotactic factor), which could explain why therapeutic
doses of aspirin-like drugs have little or no effect on
leukocyte accumulation and activation during the
inflammatory phenomenon21. As well as corticosteroids,
there are very few studies about the concomitant use of
these anti-inflammatory drugs and antimicrobial agents.
Drug interactions between amoxicillin and diclofenac
sodium were previously demonstrated in the literature12. This
study showed that both amoxicillin tissue and serum
concentrations were significantly reduced by diclofenac
sodium.
Being the corticosteroids one of the most used anti-
inflammatory agents in dentistry when a significant amount
of surgical trauma is expected2, the purpose of this study
was to verify the effect of betamethasone on serum and
tissue concentrations of amoxicillin.
MATERIAL AND METHODS
Bacterial strain. A penicillin-sensible Staphylococcus
aureus strain (ATCC 25923) was used for the in-vitro test to
determine the MIC and MBC100 by using Mueller-Hinton
broth (Merck, Darnstadt, Germany) and Salt Mannitol agar
(Merck, Darnstadt, Germany), respectively. The same strain
was used to carry out the regression line assay and the
microbiological assay of amoxicillin concentrations.
Drugs. Amoxicillin trihydrate was obtained from Sigma
Chemical Co. (St Louis, MO, U.S.A.). Betamethasone
(Celestone injectable® – Schering-Plough S/A) and
diclofenac sodium (Voltaren injectable® – Novartis
Biociências) were commercially obtained. Physiological
saline solution (0.9% NaCl) was administered to the control
animals.
Animals. Forty-eight adult male Wistar rats (Rattus
norvegicus- albinus), aged 60 days and weighing 175±25g,
were obtained from CEMIB-UNICAMP (Centro de
Bioterismo-ICLAS Monitoring/Reference Center, Campinas,
Brazil) where they were maintained under aseptic conditions.
The Institutional Review Board for Ethics in Animal Research
of University of Campinas approved all procedures (protocol
#423-1).
Granulomatous tissue model. All animals were
anesthetized with a combination of ketamine 90 mg/kg/i.m.,
and xylazine 10 mg/kg/i.m.28 and granulomatous tissue was
induced as previously described3,12. Briefly, four sterilized
polyurethane sponge discs (density 35 kg/m3) were
subcutaneously implanted in the back of all rats. These
sponge discs (Proespuma Com. & Ind. Ltd., São Paulo, Brazil)
were 12 mm in diameter and 5 mm thick, weighing 12.1±0.81mg.
Experimental groups. Seven days after the sponge
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introduction, all animals were assigned into six groups of
eight animals each: G1 - amoxicillin 25 mg/kg/p.o.; G2 –
diclofenac sodium 2.5 mg/kg/i.m.; G3 - betamethasone 0.1
mg/kg/i.m.; G4 - amoxicillin 25 mg/kg/p.o. and diclofenac
sodium 2.5 mg/kg/i.m.; G5 - amoxicillin 25 mg/kg/p.o. and
betamethasone 0.1 mg/kg/i.m.; and G6 - physiological saline
(0.9% NaCl) 1.0 mL/p.o. All drugs were administered in a
single dose.
Surgical and sampling procedures. After 90min of drug
administration, blood samples were collected by cutting the
carotid plexus of each animal under general anesthesia.
Blood samples were centrifuged and 10µL of serum was
placed on three sterilized paper discs (6.25mm) and dried at
room temperature. Granulomatous tissues were delimited
and surgically removed. All discs and two granulomatous
tissue samples of each animal were placed on Muller-Hinton
Agar plates inoculated with 108 cfu/mL of S. aureus. After
18 hours of incubation at 37oC, the inhibition zones were
measured. Two granulomatous tissue samples of each animal
were weighed and analyzed by a histological routine
technique (HE). Granulomatous tissue weights, tissue and
serum concentrations were submitted to the Kruskal-Wallis
test and Dunn test (software Bioestat 1.0® for Windows©) in
order to compare all groups.
Regression line: Amoxicillin suspensions of 0.03, 0.05,
0.07, 0.10, 0.30, 0.50, 0.70, 1.0, 3.0, 5.0, 7.0 and 10µg/mL were
made by using drug-free serum of rats and 10 µL were placed
onto dry paper-filter discs (6.25 mm). Three discs of each
concentration were placed on the Mueller Hinton agar,
previously inoculated with 108 cfu/mL of S. aureus. The
resulting inhibition zones were measured (mm) after 18 hours
of incubation at 37oC. These zones and the amoxicillin
concentrations were used to obtain the regression line (Excel
XP® - Microsoft Corporation).
RESULTS
MIC and MBC100 of amoxicillin against S. aureus ATCC
25923 were respectively 0.2µg/mL and 1.5µg/mL.
The limits of detection of the regression curve were
0.03µg/mL (12 mm of inhibition zone diameter) and 10µg/mL
(31 mm of inhibition zone diameter). The relation between
the diameter of inhibition zone (DIZ - in mm) and the
concentration of amoxicillin (CA - in µg/mL) was DIZ = (3.23
x Ln (CA)) + 24.16, which showed a coefficient of regression
(R) of 0.9851. This relation was used to estimate tissue and
serum concentrations, considering the mean of tissue
weights of each animal.
The wet weight (mg) values (mean ± s.e.m.) of the
granulomatous tissue samples were 30.25 (± 1.98), 42.81 (±
3.26), 40.25 (± 1.98), 31.25 (± 2.58), 46.5 (± 3.8) and 41.19 (±
2.22), respectively for groups 1, 2, 3, 4, 5 and 6. No statistically
significant differences were observed among groups
(p>0.05) regarding the wet weight values.
After 7 days and 90 minutes, a delimited fibrous capsule
involving the sponge was observed in all samples.
Fibroblasts, mesenchymal cells, and new capillary formation
were verified in large scale. Infectious exudate was not
observed in any of the granulomatous tissues.
Figure 1 shows amoxicillin serum and tissue
concentrations of groups 1, 4 and 5. Groups 2, 3 and 6 did
not show any inhibition zone considering both serum and
tissue samples during the microbiological assay. Just the
groups that used amoxicillin showed these inhibition zones.
Amoxicillin serum and tissue concentration were not
significantly (p>0.05) affected by betamethasone. However,
diclofenac sodium induced a reduction in both serum and
tissue amoxicillin concentrations (p<0.05).
DISCUSSION
MIC and MBC100 of amoxicillin against S. aureus ATCC
25923 strain confirmed its susceptibility14. As observed in
FIGURE 1- Amoxicillin serum and tissue concentrations (mean ± s.e.m.) considering groups 1, 4 and 5. Groups 2, 3 and 6
did not show any inhibition zone considering both serum and tissue samples. Different letters mean statistically significant
differences (p<0.05) among groups, considering serum and tissue concentrations separately
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previous studies, the microbiological method was accurate
enough to measure amoxicillin concentrations in this study12.
This method has the same precision as HPLC assay17 and it
has been widely used for determining amoxicillin
concentration5.
 According to Groppo, et al.12 (2000), the period of 7 days
used for the development of granulomatous tissue in the
present study is adequate. These authors observed that
different periods (7, 14, 21 and 28 days) for development of
granulomatous tissues in rats did not interfere with the
pharmacokinetics of amoxicillin.
The high anti-inflammatory activity of betamethasone
and diclofenac sodium in both humans2 and rats24 was
previously demonstrated. However, both anti-inflammatory
agents with or without amoxicillin were unable to reduce
tissue wet weights in the present model. Probably, the chosen
model, i.e., chronic inflammatory granulomatous tissue, was
not adequate to study anti-inflammatory properties. In
addition, a single dose could not be enough to significantly
reduce the inflammatory cells reflecting in a lower wet weight
of the granulomatous tissues.
Another factor that could contribute to this non-
significant anti-inflammatory activity is time. A previous
study11 showed a significant reduction in the wet weight of
granulomatous tissues in rats after six hours of diclofenac
sodium administration (2.5 mg/kg/i.m.) and probably 90
minutes (used at the present study) was not enough to
observe significant reduction in wet weight.
The results of the present study corroborate with
previous findings12 that showed great reduction in serum
and tissue amoxicillin concentrations caused by diclofenac
sodium. These authors observed that the drug interaction
was probably not caused by metabolism or excretion
interferences, since amoxicillin and diclofenac have different
pharmacokinetics (plasmatic protein binding, excretion and
metabolism). These same considerations about diclofenac
could be applied to betamethasone.
In the present study, betamethasone did not interfere
with serum or tissue concentration of amoxicillin when
compared with the group in which amoxicillin was
administered alone. This finding is important since the serum
concentration of amoxicillin must be clinically significant
considering prophylactic use of this antimicrobial agent2.
While amoxicillin has intestinal absorption through
passive diffusion15,26 and through oligopeptide transporter
system present mainly in kidney and intestine18 the
absorption of diclofenac occurs mainly through excretion
in the bile20. There are no data regarding the association
between peptide transporters and diclofenac absorption.
However, other drugs that have a high affinity for peptide
transporters, like amiloride30 caused high decreases in
amoxicillin concentration.
Thus, diclofenac could cause a reduction in the
amoxicillin absorption. Steroidal agents were not associated
with the same oligopeptide transporter system that is
responsible for amoxicillin absorption18, which could explain
the absence of drug interactions between both agents.
It was concluded that betamethasone did not affect the
serum and tissue amoxicillin concentrations but diclofenac
sodium significantly reduced them.
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